Selective COX-2 inhibitors, NSAIDs, aspirin, myocardial infarction

被引：35

作者：

Dalen, JE

机构：

来源：

ARCHIVES OF INTERNAL MEDICINE | 2002年 / 162卷 / 10期

关键词：

D O I：

10.1001/archinte.162.10.1091

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1091 / 1092

页数：2

共 13 条

[1] COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].

ALTMAN, R ;

CARRERAS, L ;

DIAZ, R ;

FIGUEROA, E ;

PAOLASSO, E ;

PARODI, JC ;

CADE, JF ;

DONNAN, G ;

EADIE, MJ ;

GAVAGHAN, TP ;

OSULLIVAN, EF ;

PARKIN, D ;

RENNY, JTG ;

SILAGY, C ;

VINAZZER, H ;

ZEKERT, F ;

ADRIAENSEN, H ;

BERTRANDHARDY, JM ;

BRAN, M ;

DAVID, JL ;

DRICOT, J ;

LAVENNEPARDONGE, E ;

LIMET, R ;

LOWENTHAL, A ;

MORIAU, M ;

SCHAPIRA, S ;

SMETS, P ;

SYMOENS, J ;

VERHAEGHE, R ;

VERSTRAETE, M ;

ATALLAH, A ;

BARNETT, H ;

BATISTA, R ;

BLAKELY, J ;

CAIRNS, JA ;

COTE, R ;

CROUCH, J ;

EVANS, G ;

FINDLAY, JM ;

GENT, M ;

LANGLOIS, Y ;

LECLERC, J ;

NORRIS, J ;

PINEO, GF ;

POWERS, PJ ;

ROBERTS, R ;

SCHWARTZ, L ;

SICURELLA, J ;

TAYLOR, W ;

THEROUX, P .

BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100

[2] Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. [J].

Bombardier, C ;

Laine, L ;

Reicin, A ;

Shapiro, D ;

Burgos-Vargas, R ;

Davis, B ;

Day, R ;

Ferraz, MB ;

Hawkey, CJ ;

Hochberg, MC ;

Kvien, TK ;

Schnitzer, TJ ;

Weaver, A .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) :1520-1528

[3] Antithrombotic agents in coronary artery disease [J].

Cairns, JA ;

Théroux, P ;

Lewis, HD ;

Ezekowitz, M ;

Meade, TW .

CHEST, 2001, 119 (01) :228S-252S

[4] AN APPLE A DAY OR AN ASPIRIN A DAY [J].

DALEN, JE .

ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (06) :1066-1069

[5] An overview of the 4 randomized trials of aspirin therapy in the primary prevention of vascular disease [J].

Hebert, PR ;

Hennekens, CH .

ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (20) :3123-3127

[6] Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib [J].

Konstam, MA ;

Weir, MR ;

Reicin, A ;

Shapiro, D ;

Sperling, RS ;

Barr, E ;

Gertz, BJ .

CIRCULATION, 2001, 104 (19) :2280-2288

[7] Risk of cardiovascular events associated with selective COX-2 inhibitors [J].

Mukherjee, D ;

Nissen, SE ;

Topol, EJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (08) :954-959

[8] Association between naproxen use and protection against acute myocardial infarction [J].

Rahme, E ;

Pilote, L ;

LeLorier, J .

ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (10) :1111-1115

[9] Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials [J].

Sanmuganathan, PS ;

Ghahramani, P ;

Jackson, PR ;

Wallis, EJ ;

Ramsay, LE .

HEART, 2001, 85 (03) :265-271

[10] Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis - The CLASS study: A randomized controlled trial [J].

Silverstein, FE ;

Faich, G ;

Goldstein, JL ;

Simon, LS ;

Pincus, T ;

Whelton, A ;

Makuch, R ;

Eisen, G ;

Agarwal, NM ;

Stenson, WF ;

Burr, AM ;

Zhao, WW ;

Kent, JD ;

Lefkowith, JB ;

Verburg, KM ;

Geis, GS .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (10) :1247-1255

← 1 2 →